人类带 介质干细胞衍生的细胞外囊 减少体外皮肤炎症
Tzou-Yien Lin1, Tsong-Min Chang2, Wei-Cheng Tsai3
1Department of Paediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 33305, Taiwan.
International journal of molecular sciences
|December 9, 2023
概括
人类带介质干细胞衍生的细胞外囊泡 (UCMSC-EVs) 保护皮肤细胞免受损伤. 这些EV能增强抗氧化防御,减少炎症,显示出抗衰老护肤产品的潜力.
科学领域:
- 细胞生物学 细胞生物学
- 皮肤病学 皮肤病学
- 再生医学是一种再生医学.
背景情况:
- 奥克萨佐隆诱导人体角质细胞 (HaCaT细胞) 的损伤,模仿皮肤损伤.
- 来自介细胞干细胞的细胞外囊泡 (EV) 正在研究其治疗潜力.
- 人类带介质干细胞 (UCMSC) 是强大的EVs的来源.
研究的目的:
- 调查UCMSC衍生的EVs在HaCaT细胞中抗氧化诱导的损伤的保护作用.
- 探索UCMSC-EVs的保护和抗炎作用的潜在机制.
- 评估UCMSC-EVs在抗衰老化品应用中的潜力.
主要方法:
- 在暴露于oxazolone之前,HaCaT细胞被UCMSC-EVs预处理.
- 测量了细胞活力,活性氧物种 (ROS) 水平和线粒体膜潜力.
- 分析了炎症性细胞因子 (IL-1β,TNF-α),SIRT1,P53和P65蛋白质的表达.
主要成果:
- UCMSC-EV预处理显著改善了细胞活力,并减少了ROS和线粒体损伤.
- 通过降低IL-1β和TNF-α水平,UCMSC-EV显示出抗炎作用.
- 机制分析显示SIRT1和P53增加,P65蛋白表达减少.
结论:
- 源自UCMSC的EV具有保护性质,可以抵御oxazolone诱导的皮肤细胞损伤.
- UCMSC-EVs增强细胞抗氧化剂防御系统,并表现出抗炎活性.
- 这些发现表明,UCMSC-EVs作为抗衰老护肤的功能成分具有前景.
更多相关视频
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
2.9K
04:47Author Spotlight: Advancements in Stem Cell-Derived Vascularized Organoids and Optimized Isolation of Wharton's Jelly for Enhanced MSC Production
Published on: July 5, 2024
2.2K
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
